Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Lawsuit
Lab exec turned aviator hit with $26.3 million default judgment
Compounding his troubles, the court held him in civil contempt for violating an order that prohibited him from selling his house without approval from the court.
Featured
Guideline
FDA releases final guidance on use of real-world data in regulatory submissions
Monkeypox
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
Latest News
German court lifts lower court injunction on sale of NanoString products
July 19, 2024
Vertex sues HHS for Casgevy fertility program access
July 16, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
FDA issues alert on BD vial supply shortage
July 15, 2024
Business Insights
Mergers & Acquisitions
Hologic acquires Endomag for $310M
Lawsuit
Lab exec turned aviator hit with $26.3 million default judgment
Guideline
FDA releases final guidance on use of real-world data in regulatory submissions
Pathology, histology
Clarapath hits $75M after closing latest Series B funding run
Diagnostic Technologies
Artificial Intelligence
Researchers develop AI model for breast tumor staging
Mergers & Acquisitions
GE HealthCare to buy Intelligent Ultrasound's AI business for $51M
Financing
Eden raises $10M for imaging and diagnostics AI
Lawsuit
Vertex sues HHS for Casgevy fertility program access
Diseases
Artificial Intelligence
Researchers develop AI model for breast tumor staging
Monkeypox
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
Research and Development
New consensus report targets PGx testing for 5-FU chemotherapy toxicity
Influenza
Alveo develops rapid test for avian flu
More from LabPulse.com
Hologic acquires Endomag for $310M
By
LabPulse.com staff writers
Hologic has completed its acquisition of breast cancer surgery technologies developer Endomagnetics (Endomag) for approximately $310 million.
July 26, 2024
Researchers develop AI model for breast tumor staging
By
LabPulse.com staff writers
A team of researchers has created an artificial intelligence (AI) model that can identify the different stages of ductal carcinoma in situ, a preinvasive tumor that may progress to a lethal form of breast cancer.
July 25, 2024
Leuko receives $4.5M SBIR grant for blood monitoring device
By
LabPulse.com staff writers
Medtech firm Leuko has received a $4.5 million award from the U.S. National Institutes of Health National Cancer Institute to advance the development of PointCheck, its noninvasive at-home white blood cell monitoring device.
July 24, 2024
Clarapath hits $75M after closing latest Series B funding run
By
LabPulse.com staff writers
The announcements come a little more than one year after Clarapath's acquisition of Crosscope for its advanced workflow and computational pathology tools.
July 24, 2024
Agilent Technologies acquires Biovectra for $925M
By
LabPulse.com staff writers
Agilent Technologies has signed a definitive agreement to acquire contract development and manufacturing organization Biovectra for $925 million.
July 24, 2024
New consensus report targets PGx testing for 5-FU chemotherapy toxicity
By
Liz Carey
The Association for Molecular Pathology published consensus recommendations to aid in the design and validation of clinical genotyping assays that target chemotherapy toxicity concerning the dihydropyrimidine dehydrogenase protein and the DPYD gene.
July 23, 2024
Alveo develops rapid test for avian flu
By
LabPulse.com staff writers
Diagnostics firm Alveo Technologies has developed a rapid, point-of-need diagnostic for avian influenza that can detect the H5N1 variant based on sequences published from recent human and cattle infections.
July 23, 2024
GE HealthCare to buy Intelligent Ultrasound's AI business for $51M
By
LabPulse.com staff writers
GE HealthCare has reached an agreement to acquire Intelligent Ultrasound's clinical artificial intelligence (AI) software business for approximately $51 million.
July 19, 2024
Eden raises $10M for imaging and diagnostics AI
By
LabPulse.com staff writers
Eden, a healthcare technology firm specializing in generative artificial intelligence (AI) for medical imaging and diagnostics, has raised $10 million in a recent funding round.
July 18, 2024
Diasorin C. auris test gets FDA de novo authorization
By
LabPulse.com staff writers
Diasorin has received de novo authorization from the U.S. Food and Drug Administration (FDA) for its test kit for
Candida auris
, a multidrug-resistant fungal pathogen common in healthcare settings.
July 16, 2024
Sapio Sciences launches partnership program
By
LabPulse.com staff writers
Lab informatics platform company Sapio Sciences has launched the Sapio Sciences Partner Program, a network of technology vendors, services companies, and resellers.
July 18, 2024
Danaher to launch 2 new diagnostic labs
By
LabPulse.com staff writers
Danaher is launching two CLIA- and CAP-certified labs to accelerate the firm's development of companion diagnostics and complementary diagnostics.
July 17, 2024